Archive: 11/02/2015

Improving end-of-life care: Lessons from 40 years of work

After four decades of work - first on patients' rights, then on family and caregiving relationships, and most recently on systemic reform—we now know that it will take additional efforts in all three areas to improve care ...

Diabetes drug spurs host defense

Pioglitazone, a medication approved for treatment of type 2 diabetes, can help bypass genetic defects in chronic granulomatous disease to help white blood cells fight bacterial infections, according to researchers at National ...

page 2 from 10